Begin main content

Off-Label Use of Intravenous Immunoglobulin for Hematological Conditions: Clinical Effectiveness

Last updated: October 24, 2017
Project Number: RB1150-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of the off-label use of intravenous or subcutaneous immunoglobulin for the treatment of hematological conditions?

Key Message

Three systematic reviews (one with meta-analyses), four randomized controlled trials, and four non-randomized studies were identified regarding the clinical effectiveness of the off-label use of intravenous or subcutaneous immunoglobulin for the treatment of hematological conditions.